Abstract
Pharmacoresistant temporal lobe epilepsy affects millions of people around the world with uncontrolled seizures and comorbidities, like anxiety, being the most problematic aspects calling for novel therapies. The intrahippocampal kainic acid model of temporal lobe epilepsy is an appropriate rodent model to evaluate the effects of novel interventions, including glycolysis inhibition, on epilepsy-induced alterations. Here, we investigated kainic acid-induced changes in the dorsal hippocampus (dHPC) and basolateral amygdala (BLA) circuit and the efficiency of a glycolysis inhibitor, 2-deoxy D-glucose (2-DG), in resetting such alterations using simultaneous local field potentials (LFP) recording and elevated zero-maze test. dHPC theta and gamma powers were lower in epileptic groups, both in the baseline and anxiogenic conditions. BLA theta power was higher in baseline condition while it was lower in anxiogenic condition in epileptic animals and 2-DG could reverse it. dHPC-BLA coherence was altered only in anxiogenic condition and 2-DG could reverse it only in gamma frequency. This coherence was significantly correlated with the time in which the animals exposed themselves to the anxiogenic condition. Further, theta-gamma phase-locking was lower in epileptic groups in the dHPC-BLA circuit and 2-DG could considerably increase it.
Similar content being viewed by others
Introduction
Epilepsy is one of the most complicated neural diseases with a high incidence among the human population1,2. It is characterized by increased neuronal excitability and appears as seizures; moreover, its many comorbidities, including anxiety, have a deep impact on the patients’ personal and social lives. Epilepsy has no certain treatment and the seizures and comorbidities are not controlled effectively in patients with pharmacoresistant epilepsies like temporal lobe epilepsy3.
Temporal lobe epilepsy has the highest rate of affliction among other focal epilepsies, and it poses a strong resistance to clinically available medications. Moreover, the current drugs have severe side effects, decreasing life quality even further. Hence, finding competent and safe therapies is of great importance4.
Although the effects of altered metabolism in epileptogenesis have been investigated5,6 the fundamental role of metabolism in regulating neuronal excitability and network circuit activity is not well determined. Metabolic manipulations like glycolysis and lactate dehydrogenase inhibition, which leads to severe energy deprivation of neurons, have been effective in controlling seizures and comorbidities in many animals studies7,8,9,10,11,12,13,14. Inhibition of metabolism by glycolysis inhibitors like 2-deoxy d-glucose (2-DG) has attracted attention not only because they are effective but also because they are rather safe and well tolerated15; indeed, 2-DG has had promising results in attenuating cancerous cell growth in clinical trials16, and is in clinical use to treat Covid-1917.
Many animal models of epilepsy have been used to evaluate the efficacy of novel therapies; among which, the intrahippocampal kainic acid model of temporal lobe epilepsy is believed to be a proper human temporal lobe epilepsy simulator because of the instantaneous seizures and hippocampal sclerosis seen in this model18,19. Hippocampal damage may lead to changes in cognitive function, including anxiety. Moreover, the model reveals a high level of resistance to the available medications20.
Dorsal hippocampus (dHPC) plays key roles in cognitive behaviors, including anxiety-like behavior; even though many lesion studies in rodents have shown that ventral hippocampus (vHPC) is more important in anxiety-like behavior compared to dHPC21,22, dHPC inhibition alters elevated plus maze parameters23. Emerging evidence shows that dHPC is involved in the acquisition of anxiety-like behaviors through various mechanisms including its connectivity to several brain regions such as the raphe nucleus and amygdala; potentiation of serotonergic inputs from the raphe nucleus to dHPC leads to increased anxiety-like behavior24,25. Besides hippocampus, amygdala is another key region for mediating anxiety-like behavior26,27. It is the first structure which receives emotional information from sensory cortices, integrates and relays this information to the medial prefrontal cortex. The hippocampus mediates this connection between the amygdala and prefrontal cortex28. The basolateral nucleus of the amygdala (BLA) is the main sub-region of the amygdala that is involved in anxiety-like behavior29.
Here, we used local field potential (LFP) recording while the animals were performing elevated zero-maze and as well as baseline condition to examine the changes in the dorsal hippocampus-basolateral amygdala neural circuit in anxiety-like behavior in the intrahippocampal kainic acid model of temporal lobe epilepsy, and following inhibition of glycolysis.
LFP recording provides us with the electrical activity in neuronal populations near the recording electrode. The signals obtained from different regions, then, can be analyzed simultaneously to reveal the connection between these structures. When the animals are doing a behavioral test, LFP recording can offer important information about how brain regions and their electrical connectivity are translated into behavioral functioning.
We hypothesized that dHPC and BLA contribute to anxiety-like behavior and their connectivity may be altered when the animals are anxious compared to the baseline condition. Moreover, we assumed that due to the severe alterations in dHPC following kainic acid injection, electrophysiological properties of dHPC and BLA, as well as dHPC-BLA connectivity, are altered in this epileptic model when the animals are exposed to anxiogenic condition and these electrical alterations are correlated to the anxiety-like behavior. We also attempted to assess the effects of 2-DG, a glycolysis inhibitor, on these possible alterations in epileptic animals. As we very recently reported that the locomotion status of mice interferes with all zero-maze parameters except for body stretching frequency30, which is the most emotionally driven behavior in the zero-maze test31, here we defined the time in which the animals were body stretching as an anxiogenic condition and compared to the baseline condition.
The present study, hence, aimed to investigate if dHPC-BLA circuit is a role player in anxiety-like behavior in rodents, as well as how the circuit is affected by epilepsy induction. Moreover, we attempted to evaluate the effect of glycolysis inhibition, a candidate as a novel antiepileptic intervention, on epilepsy-induced alterations.
Materials and methods
Animals
This study was carried out on 18 adult male NMRI mice (30 to 35 g of weight; Pasteur institute, Tehran). The animals were housed with free access to a standard pellet diet and tap drinking water ad libitum. They were kept in a temperature-controlled (23 ± 2 °C) animal house free from any source of chemical or noise pollution under the 12:12 h light: dark cycle. All animals received human care and gentle handling throughout the study, as it has been shown that proper techniques and frequency of handling were used to reduce stress and anxiety32. The mice were single housed after the surgery; although social housing is deemed to be the optimal way of housing, previous studies showed that single housing does not significantly affect behavioral tests in mice33. Hence, we single-housed the mice to prevent possible electrode dislocation as mice tend to remove each other’s cement fixed on their skull. All experimental procedures and animal care conformed to the guidelines of ARRIVE and National Institute of Health Guide for the Care and Use of Laboratory Animals and were approved by the Biomedical Research Ethics Committee of the National Institute for Medical Research Development (Approval ID: IR.NIMAD.REC.1399.259) and the Ethics Committee of Shahid Beheshti University of Medical Sciences (Authorization code: IR.SBMU.MSP.REC.1400.630).
Study design
This study intended to assess electrophysiological impact of epilepsy induction by kainic acid injection into dHPC on the neural circuit between dHPC and BLA, which are role players in anxiety-like behavior, and how dHPC-BLA circuit is altered when the animals are exposed to the anxiogenic condition. Three separate groups were used: control group received intrahippocampal plus i.p. saline; the epileptic group received intrahippocampal kainic acid (see below) plus i.p saline; epileptic + 2-DG group received intrahippocampal kainic acid and i.p 2-DG. Intrahippocampal kainic acid or saline were injected on the 0th day; i.p saline or 2-DG were injected from 21st to the 27th days, once a day. 300 mg/kg 2-DG was dissolved in saline and injected with a volume of 0.1 mL/10 g of body weight. This dose was chosen according to the previous studies12,13. Saline was injected with the same volume (Fig. 1A). On the day of the experiment (27th day), 2-DG or saline were injected 90 min prior to simultaneous zero-maze test and LFP recording, a time in which 2-DG induced ketosis is noted34.
Surgery, epilepsy induction and electrodes implantation
As shown previously, intrahippocampal kainic acid injection induces temporal lobe epilepsy in rodents7,30. Briefly, mice underwent stereotaxic surgery. They were anesthetized with an intraperitoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg). The ear bars were placed delicately prior to muzzle fixation. Lidocaine 2% was injected under the scalp skin 5 min before making an approximately 2 cm incision in the skin. Following Bregma-Lambda adjustment to a plane level, three holes were made by a fine drill. 0.8 nmol kainic acid was dissolved in 40 nL normal saline and directly injected into the left dorsal hippocampus (−1.6 mm to the Bregma, 1.6 from the midline, and 1.2 mm deep from the dura mater) according to the directions of Paxinos and Franklin atlas (2001). To prepare electrodes, 2 stainless steel wires (127 μm in diameter, A.M. system Inc., USA) were intertwined to give the electrode suitable strength and flexibility. The electrodes, then, were soldered to a connector and placed in dHPC (−2.1 mm AP, 1.5 mm ML, 1.2 mm DV) and BLA (−1.4 mm AP, 2.5 mm ML, 3.7 mm DV). 6 screws (one as the reference electrode above the cerebellum) were screwed to the scalp. Lastly, dental cement was used to fix the electrodes. As status epilepticus following intrahippocampal kainic acid is non-convulsive, verification of the model induction was confirmed by frequent interictal epileptiform activity (see below for details) as well as severe cell loss and neuronal degeneration in the dorsal CA1 (Fig. 2 A&B).
Elevated zero-maze test
Anxiety-like behavior was evaluated by using zero-maze apparatus35. The apparatus (60 cm in diameter, 5 cm wide circular corridor, 16 cm high walls and 60 cm high from the floor) was made of wood and painted black. After 30 min of habituation to the experiment room, each animal was placed in an intersection between open and closed arm facing the closed arm. During the following 5 min, the animals were videotaped then analyzed offline to find the duration of body stretching. Behavioral and electrical recordings were synchronized by an LED and body stretching times were extracted and analyzed.
Local field potentials recordings
The implanted electrodes plugged into a miniature buffer headstage with a high-input impedance (BIODAC-A, TRITA WaveGram Co., Tehran, Iran). The headstage was connected to a main AC coupled amplifier (1000 × amplification) and to the recording system (BIODAC-ESR18622, TRITA WaveGram Co., Tehran, Iran). The LFP signals were recorded for one hour at a 1 kHz sample rate and low-pass filtered at 250 Hz while the animals were freely moving. Interictal epileptiform discharges were defined as sharp-waves, having more than twofold amplitude compared with baseline, as well as having a frequency between 1 to 20 Hz. The discharges were detected and analyzed by MATLAB software (MathWorks, Inc. version 2016a. http://www.mathworks.com). Frequent interictal discharges endorsed epilepsy induction. At the end of the experiments, brains were removed to verify the proper placement of the electrodes (Fig. 1B).
Local field potential analyses
Power spectrum density and coherence
Theta (4–12 Hz) and gamma (30–50 Hz) oscillations were identified by band-pass filtering the raw LFP signals. To compute power spectral density (PSD), Welch’s periodogram function of MATLAB (MathWorks, Inc. version 2016a. http://www.mathworks.com) was utilized. We also used coherency spectra to identify the dynamic functional connectivity between different brain regions and measure the similarities between signals in the frequency domain. For this, the e coherence spectra of the dHPC-BLA circuit were analyzed by calculating magnitude-squared coherence using the “mscohere” function in MATLAB. Both power and coherence spectra computing carried 1 s hamming windows with a 90% overlap on 60 s segments of resting state as well as signals during body stretching in zero maze. In order to obtain accurate magnitudes of all the frequency components of the signals, a hamming window filter was used to reduce spectral leakage. Power spectrum density (PSD) measures a signal’s power content versus frequency while coherence is used to determine if brain regions have similar neuronal oscillatory activity across frequency steps in theta and gamma bands.
Theta-gamma phase-phase locking
Various types of cross-frequency coupling give the notion that brain regions may exert diverse coding strategies to transform complicated information36. Theta-gamma phase-locking analysis has been demonstrated to take part in information routing in which multiple gamma cycles are consistently entrained during one cycle of theta37. Briefly, Hilbert transform of the filtered signals was used to obtain the phase of LFP signals corresponding to both theta and gamma frequency bands. The obtained phases, then, were binned into 120 bins (3-degrees width per bin), and then their two-dimensional histogram matrix was calculated, where its (i.j)th element was the proportion of the number of samples, while the theta phase was located in ith bin and the gamma phase was in jth bin, simultaneously. To smoothen the histogram, a Gaussian kernel with a standard deviation of 3 and a size of 30 bins was used. For ‘Original’ in Fig. 6A, we used the same time window to obtain theta and gamma then ‘Time Shift’ procedure was created to surrogate epochs for investigating the reliability of surrogate methods for detecting n:m phase-locking.
Simultaneous zero-maze test and local field potential recording
Here, we sought to reveal how brain oscillations were affected by facing an anxiogenic condition compared to a baseline condition in healthy and epileptic mice. Moreover, how 2-DG can affect kainic acid-induced changes? With this regard, we extracted the time in which the mice were doing body stretching posture; they lengthen their body on the corridor to explore the open arms while a part of their body is still in the closed arm. This posture is considered to be the time in which the animal is anxious most31, hence, we defined it as an anxiogenic condition. the LFP parameters were calculated in this anxiogenic condition and compared to the values extracted from the baseline condition; the baseline condition was a 120 s epoch in which the animals were immobile but not asleep.
Detection of degenerating neurons and apoptosis by Fluoro-Jade B and DAPI staining
To detect degenerating neurons in kainic acid-treated dorsal hippocampi, Fluoro-Jade B staining was performed as described before38; the mice were anesthetized (100 mg/kg ketamine and 10 mg/kg xylazine, i.p) on the day 27 and perfused transcardially with a cold fixative containing 4% paraformaldehyde and 1.33% picric acid in 0.1 M phosphate buffer (PB, pH 7.4) following 0.9% saline perfusion. The brains were then dissected out from the skull, post-fixed overnight in the same fixative at 4 °C and cryoprotected by being immersed in 20% sucrose until they sank. The brains were freeze-sectioned coronally at 10 µm thickness, between the AP 1.2 mm and 2.4 mm posterior to the Bregma (Paxinos & Franklin, 2001) using a cryostat (Leica CM1850, Germany). The slides were first immersed in 1% sodium hydroxide in 80% ethanol for 5 min; this was followed by 2 min in ethanol 70% prior to 10 min in 0.06% potassium permanganate solution. The slides, then, were immersed in 0.0004% Fluoro-Jade B (FJB) solution for 20 min and rinsed with distilled water afterwards. To detect apoptosis, the slides were counterstained with DAPI staining solution, and then washed with distilled water, air dried, cleared, and coverslipped. Imaging was performed using a fluorescent microscope (Olympus, BX51 TRF, USA) equipped with a DP72 CCD camera (Olympus, Japan). ImageJ software (National Institutes of Health, Bethesda, Maryland, USA. http://imagej.nih.gov/ij) was used to prepare the images.
Results
Intrahippocampal kainic acid led to ubiquitous interictal epileptiform activity and severe cell loss as well as ongoing neuronal degeneration in dHPC
First, we sought to confirm the model induction by assessing 1-h continuous LFP recording and cell loss in the dorsal hippocampus. As it is illustrated in Fig. 2A, interictal epileptiform discharges were frequently seen during LFP accompanied by severe cell loss and ongoing neuronal degeneration in dorsal CA1 of kainic acid-treated animals (Fig. 2B). 2-DG could not exert any histological beneficial effects as it was injected long after kainic acid injection (see above). Hence, intrahippocampal kainic acid injection leads to frequent interictal epileptiform activity and severe cell loss, as well as neurons undergoing degeneration in dorsal CA1.
Epilepsy induction disrupted theta and gamma powers
To assess the alterations of oscillatory activity following epilepsy induction, we evaluated PSD in dHPC during both baseline and anxiogenic conditions. Theta and gamma powers were significantly lower in the dorsal hippocampus of the epileptic animals meanwhile 2-DG failed to reverse decreased power in epileptic animals (Fig. 3A&C).
Further, theta power of BLA during baseline condition increased in epileptic and epileptic + 2-DG groups compared to control animals (Fig. 3B); in anxiogenic condition (the time during which the mice were stretching their body from closed arms to open arms), however, high theta power was significantly lower in the epileptic group compared to control and epileptic + 2-DG groups (Fig. 3D). Nonetheless, BLA gamma power was not notably different between the groups, both in baseline and anxiogenic conditions (Fig. 3B&D). PSD assessment, therefore, indicates that dHPC powers decrease both in theta and gamma frequency bands in baseline and anxiogenic conditions in epileptic animals while BLA theta power is higher in epileptic animals only when they are immobile; in anxiogenic condition, BLA theta power decreases in epileptic animals and 2-DG can reverse it considerably.
Epilepsy induction altered coherence in dHPC-BLA circuit in anxiogenic condition
Having noted the altered power values in epileptic animals both in dHPC and BLA, we hypothesized that the connectivity between these two structures had changed. Our assessment of coherence in the dHPC-BLA circuit revealed no significant difference among the groups during the baseline condition (Fig. 4A). However, in the anxiogenic condition in zero-maze apparatus, amazingly, theta coherence between dHPC and BLA was significantly higher in control groups compared to epileptic animals. 2-DG could not reset the decreased coherence in epileptic animals at theta frequency band. Likewise, coherence at the gamma band was significantly lower in epileptic animals while a rise was found in the epileptic + 2-DG group compared to the epileptic group (Fig. 4B). As a conclusion, the difference in coherence values between the groups was evident only when the animals were exposed to the anxiogenic condition. Only in the case of the gamma band, 2-DG could reverse decreased coherence in epileptic animals.
Coherence in dHPC-BLA circuit is correlated to anxiogenic condition
As epileptic induction disrupted the connection between dHPC and BLA, we further evaluated its correlation with the anxiogenic condition. Our findings illustrated that the coherence values between dHPC and BLA at both theta and gamma frequencies were negatively correlated with the time in which animals exposed themselves to the anxiogenic condition in all three groups (Fig. 5). Moreover, the absolute value of the correlation in the theta band, although not significantly, was reduced in epileptic animals, while 2DG led to an increase in the correlation compared to the epileptic group. However, no noticeable changes in the correlation between coherence in the dHPC-BLA circuit with the anxiogenic condition were noted in the gamma band between the control and epileptic group; this correlation in the gamma band, however, was slightly elevated in the epileptic + 2-DG group. Therefore, coherence in the dHPC-BLA circuit is correlated to the spent time in the anxiogenic condition in the control and the epileptic group, even though it is weaker in epileptic animals. 2-DG reversed this weakened correlation.
Phase-phase coupling between dHPC and BLA was different in baseline and anxiogenic conditions
We finally investigated altered functional connectivity between dHPC and BLA using phase-phase coupling analysis. First, our findings revealed that theta-gamma phase-locking (BLA gamma phase locked to dHPC theta phase) was disrupted in epileptic animals (Fig. 6B, see below). Moreover, in baseline condition, the phase-locking values were significantly lower in epileptic animals compared to controls only in 1:1, 1:4 and 1:25. 2-DG significantly reversed the alteration in only 1:4 (Fig. 6C). In the anxiogenic condition, however, in the points from 1:1 to 1:22, phase-locking was much stronger in control animals compared to the epileptic group. Interestingly, 2-DG could substantially increase phase-locking in many points (Fig. 6D). Hence, the dHPC theta phase regulates the BLA gamma phase both in baseline and anxiogenic conditions, but it is much stronger in the latter, indicating elevated dHPC-BLA connectivity in anxiety. The phase-locking was weaker in epileptic animals and 2-DG could reset it at many points.
Coherence and phase-locking values in the dHPC-BLA circuit were much higher in anxiogenic condition
Apart from changes induced by epilepsy induction we reported, the differences in the LFP parameters within each group in anxiogenic condition compared to baseline could indicate the importance of dHPC-BLA circuit in anxiety-like behavior. Interestingly, in the anxiogenic condition, theta and gamma powers were significantly lower in the epileptic group, but not in control mice, compared to baseline. However, 2-DG could reverse the alterations induced by kainic acid treatment. dHPC-BLA circuit coherence and phase-locking, however, were substantially higher when the animals were in anxiogenic conditions compared to the baseline in all the experimental groups. This may suggest the importance of the dHPC-BLA circuit in anxiety-like behavior in mice (Table 1).
Discussion
In the present study, we set out to address the electrophysiological signature of dHPC-BLA circuit in anxiety-like behavior in intact and epileptic mice. Moreover, we evaluated the effects of glycolysis inhibition on epilepsy-induced changes. Our findings from simultaneous LPF recording during anxiety-like behavior and histochemical staining indicate that intrahippocampal kainic acid injection leads to severe cell loss as well as generating frequent interictal epileptiform activity in the CA1 pyramidal cell layer endorsing epilepsy induction. Moreover, even 27 days after kainic acid injection, many neurons undergo a degeneration process. This severe cell loss and degeneration bring about profound alterations in the electrical properties of kainic acid injected dHPC as well as intact BLA. Moreover, the dHPC-BLA circuit is disrupted in epileptic animals, as was evidenced by decreased coherence in the circuit. This decrease in coherence is negatively correlated to the time in which mice expose themselves to anxiogenic conditions (body stretching posture). Furthermore, weakened theta-gamma phase-locking between dHPC and BLA is noted in the epileptic animals. Most interestingly, the alterations following epilepsy induction are obvious only when the animals are exposed to the anxiogenic condition compared to baseline condition; this is true, especially in the case of coherence and phase-locking assessments. Moreover, the connectivity between dHPC and BLA is substantially higher when the animals are anxious regardless of the groups indicating the importance of dHPC-BLA circuit in anxiety-like behavior.
Decreased theta power, which is the dominant brain oscillation in the hippocampus, has been reported in the intrahippocampal kainic acid model of temporal lobe epilepsy39. We have also very recently reported that intrahippocampal kainic acid injection leads to severe cellular and electrophysiological alterations in dHPC30.
Unlike BLA and vHPC which are directly interconnected, dHPC is not directly connected to BLA; rather, the connection between the two structures has been reported to be mediated by lateral entorhinal and perirhinal cortices; the proposed circuit involves outputs from dorsal CA1/subiculum to entorhinal/perirhinal cortices, which are robustly connected to amygdala40. BLA-vHPC circuit is important in regulating anxiety41. Likewise, dHPC-BLA hyperconnectivity was reported in rodents with chronic exposure to anxiogenic conditions in the early stages of life41. Moreover, injection of both the serotonin receptor (5-HT6) agonist and antagonist into dHPC exerts anxiolytic effects; moreover, amygdala dopamine level is altered by changes in serotonin signaling, which plays an important role in anxiety25,43. Most of the previous studies have used lesions or pharmacological interventions to inhibit or stimulate the brain regions and then performed behavioral experiments to reveal how the inhibition or stimulation affects behavioral functioning.
Glycolysis inhibition by 2-DG can reverse many alterations induced by epilepsy induction including gamma coherence and theta-gamma phase-locking in dHPC-BLA circuit. Further, it increases BLA theta power when the epileptic animals are exposed to anxiogenic condition.
The decreased theta power in dHPC we reported here, both in baseline and anxiogenic conditions, is consistent with previous findings showing attenuated theta oscillations in kainic acid-treated CA139. Both hippocampal pyramidal neurons and interneurons have been reported to contribute to the generation of hippocampal theta oscillations; indeed, hippocampal theta rhythm is generated by the medial septum, nucleus incertus and entorhinal cortex and pyramidal neurons follow this rhythm44; in turn, the pyramidal neurons project back to the medial septum and help the maintenance of the theta rhythm45,46. The GABAergic interneurons play a crucial role in generating such coordination between the pyramidal neurons and theta generators47,48,49. Hence, such severe cell loss and ongoing degeneration in CA1 would lead to such decrement in theta power we noted. Hippocampal gamma oscillations, however, are generated more locally. Two possible mechanisms have been explored regarding whether special synaptic properties at the gamma generating loci are the main players or neuromodulation (cholinergic for instance) plays the main role in generation of hippocampal gamma oscillations. Regardless of which mechanism is more important, both emphasize on the interactions between pyramidal and interneurons50,51, which are disrupted in the kainic acid-treated hippocampus as was evidenced by severe cell loss. Therefore, a gamma power decrement in CA1 is expected as we demonstrated. 2-DG was unable to reverse the decreased power as it was injected long after the cell loss.
Interestingly, kainic acid-treated animals revealed higher theta power in BLA in baseline condition compared to control and 2-DG treatment could not reverse it in epileptic animals. It is already known that the kainic acid-induced lesion does not spread out of the hippocampus at low doses like ours52,53. Hence, alterations in dHPC are likely to affect its connection with the other parts of the limbic formation including BLA. BLA receives information from somatosensory cortices and relays them to the hippocampus; the information, then, is evaluated by the hippocampus and sent back to BLA to affect behavior in response to various emotional stimuli40. This interconnection between BLA and dHPC is mediated by the entorhinal cortex54. When the animals are in the baseline condition, various somatosensory stimuli are sent to BLA and the dHPC to be evaluated; it is possible that due to attenuation of dHPC outputs to BLA following epilepsy induction, BLA theta power increases, as we showed here, to maintain its cooperation with dHPC. Consistently, gamma power was not affected in BLA in epileptic mice as it is known that synchronizing rhythm within the limbic formation, dHPC and BLA included, is theta, not gamma rhythm55. When exposed to anxiogenic condition, however, we report that BLA theta power is lower in epileptic animals and 2-DG substantially resets the power. Indeed, theta power in BLA increased in anxiogenic condition compared to baseline in control animals while it decreased in the anxiogenic condition in epileptic animals. To address such disrupted power in both BLA and dHPC we evaluated coherence in the dHPC-BLA circuit. It has been reported that the LFP power is associated with low or high-activity of the mice rather their location (open arm or open arm) in elevated plus maze test56. Moreover, it has been demonstrated that a short time before deciding to avoid or approach to open arm in elevated plus maze, vHPC-BLA, but not dHPC-BLA circuit plays a role in the risk assessment57. Here, analyzing exactly the time in which the animals were anxious most, importance of dHPC-BLA circuit emerges (see below).
In the baseline condition, no altered theta coherence was noted in the circuit between the groups. Amazingly, theta coherence between dHPC and BLA was much stronger when the animals were anxious in control animals suggesting the importance of this circuit in anxiety-like behavior. This coherence was weaker in epileptic animals and 2-DG could not strengthen it. Here we could speculate that decreased theta power in both BLA and dHPC led to such weaker coherence between them in epileptic animals when they were exposed to the anxiogenic condition. Not only is the dHPC-BLA circuit regulated by cortical input, but it may be adjusted by other subcortical areas like median raphe nucleus (MRN). MRN outputs to dHPC have been reported to regulate anxiety behavior24,25. interestingly, stimulation of serotonergic projections from MRN to dHPC leads to an increase in BLA dopamine which plays a role in anxiety behavior25,43. disrupted MRN-dHPC connection following severe cell loss and deformation of dorsal CA1, hence, may be another mechanism leading to decreased coherence between dHPC and BLA.
In the epileptic group, gamma coherence diminished in the dHPC-BLA circuit in the anxiogenic condition and 2-DG could significantly reverse it. This is interesting because BLA gamma power was not affected by epilepsy induction. decreased dHPC gamma power did not lead to gamma coherence decrement in baseline condition; hence, disrupted dHPC theta power might have led to such a decrease in gamma coherence; moreover, 2-DG could reverse it probably by increasing BLA gamma power as we showed here. Addressing this speculation begs the question whether BLA gamma activity is regulated by dHPC theta oscillations. Theta-gamma phase-locking has been shown to be a mechanism through which various regions cross-talk37. Moreover, medial prefrontal cortex theta phase regulates BLA firing leading to safety seeking of mice58. Here we analyzed theta-gamma phase-locking between the two structures. It was amazing that the coupling was much stronger when the animals were anxious suggesting that the degree to which dHPC theta regulates BLA gamma, is an important factor in anxiety-like behavior; to explain more, decreased phase-locking between dHPC and BLA may lead to decreased gamma coherence we demonstrated here; Moreover, we report that coherence in the dHPC-BLA circuit is negatively correlated to spent time in anxiogenic condition. Consequently, decreased gamma coherence resulting from attenuated theta-gamma phase-locking in the dHPC-BLA circuit leads to more spent time in the anxiogenic condition in epileptic animals compared to control values.
Conclusion
Our data indicate that severe cell loss in dHPC leads to deep alterations in the electrophysiological properties of dHPC as well as BLA in intrahippocampal kainic acid-treated mice. Decreased dHPC theta and gamma power occur in baseline condition while BLA theta power is elevated maybe because BLA is trying to maintain its connectivity with damaged dHPC. 2-DG had no notable effects on baseline theta and gamma power. In anxiogenic condition, however, dHPC theta and gamma power reduces in epileptic animals; while, amazingly, BLA theta power decreases may be due to the fact its connectivity with dHPC is disrupted. Coherence evaluation in the dHPC-BLA circuit revealed no significant difference between control and epileptic groups in the baseline condition. Nevertheless, importantly, in the anxiogenic condition, the coherence increases dramatically illuminating the importance of the dHPC-BLA circuit in anxiety-like behavior; this is endorsed by the negative correlation between the dHPC-BLA circuit and spent time in the anxiogenic condition. This correlation, although weaker, was noted in epileptic animals as well. Having noted decreased gamma coherence in the circuit while BLA power was not affected by epilepsy induction, we set out to assess if dHPC theta regulates BLA gamma; phase-locking analysis revealed that dHPC theta highly regulates BLA gamma in the control group, especially in anxiogenic condition. Decreased phase-locking between the dHPC-BLA, hence, may lead to decreased BLA gamma power and dHPC-BLA coherence as we noted here. Hence, analyzing the time in which the animals are anxious most instead of analyzing the whole time the animals are in open or closed arm in the elevated mazes offer more precise circuit-level signature of neural circuits regarding anxiety-like behavior, as we reported here. 2-DG could reverse decreased gamma power and weakened coherence and phase-locking between dHPC and BLA. Therefore, since patients with temporal lobe epilepsy show hippocampal sclerosis (indicating cell loss), prescribing agents like 2-DG which are capable of resetting disrupted changes in limbic formation especially between the hippocampus and amygdala which play a crucial role in emotion and cognition, could exert beneficial effects.
Data availability
The data are available from the corresponding author on a reasonable request.
References
Fiest, K. M. et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology 88(3), 296–303. https://doi.org/10.1212/WNL.0000000000003509 (2017).
Hunter, M. B. et al. Incidence of early-onset epilepsy: A prospective population-based study. Seizure. 75, 49–54. https://doi.org/10.1016/j.seizure.2019.12.020 (2020).
Medel-Matus, J. S., Orozco-Suárez, S. & Escalante, R. G. Factors not considered in the study of drug-resistant epilepsy: Psychiatric comorbidities, age, and gender. Epilepsia Open. 7(Suppl 1), S81–S93. https://doi.org/10.1002/epi4.12576.2 (2022).
Bruxel, E. M., do Canto, A. M., Bruno, D. C. F., Geraldis, J. C. & Lopes-Cendes, I. Multi-omic strategies applied to the study of pharmacoresistance in mesial temporal lobe epilepsy. Epilepsia Open. 7(Suppl 1), S94–S120. https://doi.org/10.1002/epi4.12536 (2022).
Alqurashi, R. S. et al. Warburg-like metabolic program coordinates Wnt, AMPK, and mTOR signaling pathways in epileptogenesis. PLoS ONE 16(8), e0252282. https://doi.org/10.1371/journal.pone.0252282 (2021).
Rho, J. M. & Boison, D. The metabolic basis of epilepsy. Nat. Rev. Neurol. 18(6), 333–347. https://doi.org/10.1038/s41582-022-00651-8 (2022).
Sada, N., Lee, S., Katsu, T., Otsuki, T. & Inoue, T. Epilepsy treatment. Targeting LDH enzymes with a stiripentol analog to treat epilepsy. Science 347(6228), 1362–1367. https://doi.org/10.1126/science.aaa1299 (2015).
Long, Y. et al. 2-Deoxy-D-Glucose Exhibits anti-seizure effects by mediating the netrin-G1-KATP signaling pathway in epilepsy. Neurochem. Res. 44(4), 994–1004. https://doi.org/10.1007/s11064-019-02734-3 (2019).
Nikbakht, F., Belali, R., Rasoolijazi, H. & Mohammad Khanizadeh, A. 2-Deoxyglucose protects hippocampal neurons against kainate-induced temporal lobe epilepsy by modulating monocyte-derived macrophages (mo-MΦ) and progranulin production in the hippocampus. Neuropeptides 76, 101932. https://doi.org/10.1016/j.npep.2019.05.003 (2019).
Shao, L. R. & Stafstrom, C. E. Glycolytic inhibition by 2-deoxy-d-glucose abolishes both neuronal and network bursts in an in vitro seizure model. J. Neurophysiol. 118(1), 103–113. https://doi.org/10.1152/jn.00100.2017 (2017).
Yang, H. et al. The antiepileptic effect of the glycolytic inhibitor 2-deoxy-D-glucose is mediated by upregulation of K(ATP) channel subunits Kir6.1 and Kir6.2. Neurochem. Res. 38(4), 677–685. https://doi.org/10.1007/s11064-012-0958-z (2013).
Stafstrom, C. E., Roopra, A. & Sutula, T. P. Seizure suppression via glycolysis inhibition with 2-deoxy-D-glucose (2DG). Epilepsia. Suppl 8, 97–100. https://doi.org/10.1111/j.1528-1167.2008.01848.x (2008).
Gasior, M., Yankura, J., Hartman, A. L., French, A. & Rogawski, M. A. Anticonvulsant and proconvulsant actions of 2-deoxy-D-glucose. Epilepsia 51(8), 1385–1394. https://doi.org/10.1111/j.1528-1167.2010.02593.x (2010).
Garriga-Canut, M. et al. 2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat. Neurosci. 9(11), 1382–1387. https://doi.org/10.1038/nn1791 (2006).
Leiter, I., Bascuñana, P., Bengel, F. M., Bankstahl, J. P. & Bankstahl, M. Attenuation of epileptogenesis by 2-deoxy-d-glucose is accompanied by increased cerebral glucose supply, microglial activation and reduced astrocytosis. Neurobiol. Dis. 130, 104510. https://doi.org/10.1016/j.nbd.2019.104510 (2019).
Goel, R. 2-Deoxy-d-glucose: From diagnostics to therapeutics. Int. J. Basic Clin. Pharmacol. 10, 732–737. https://doi.org/10.18203/2319-2003.ijbcp20212086 (2021).
Sahu, K. K. & Kumar, R. Role of 2-deoxy-d-glucose (2-DG) in COVID-19 disease: A potential game-changer. J. Fam. Med. Prim. Care. 10(10), 3548–3552. https://doi.org/10.4103/jfmpc.jfmpc_1338_21 (2021).
Quiske, A., Helmstaedter, C., Lux, S. & Elger, C. E. Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. Epilepsy Res. 39(2), 121–125. https://doi.org/10.1016/s0920-1211(99)00117-5 (2000).
French, E. D., Aldinio, C. & Schwarcz, R. Intrahippocampal kainic acid, seizures and local neuronal degeneration: Relationships assessed in unanesthetized rats. Neuroscience 7(10), 2525–2536. https://doi.org/10.1016/0306-4522(82)90212-3 (1982).
Buckinx, A. et al. Translational potential of the ghrelin receptor agonist macimorelin for seizure suppression in pharmacoresistant epilepsy. Eur. J. Neurol. 28(9), 3100–3112. https://doi.org/10.1111/ene.14992 (2021).
Bannerman, D. M. et al. Regional dissociations within the hippocampus–memory and anxiety. Neurosci. Biobehav. Rev. 28(3), 273–283. https://doi.org/10.1016/j.neubiorev.2004.03.004 (2004).
Trivedi, M. A. & Coover, G. D. Lesions of the ventral hippocampus, but not the dorsal hippocampus, impair conditioned fear expression and inhibitory avoidance on the elevated T-maze. Neurobiol. Learn. Mem. 81(3), 172–184. https://doi.org/10.1016/j.nlm.2004.02.005 (2004).
Zhang, W. N., Bast, T., Xu, Y. & Feldon, J. Temporary inhibition of dorsal or ventral hippocampus by muscimol: Distinct effects on measures of innate anxiety on the elevated plus maze, but similar disruption of contextual fear conditioning. Behav. Brain Res. 262, 47–56. https://doi.org/10.1016/j.bbr.2013.10.044 (2014).
Almada, R. C., Borelli, K. G., Albrechet-Souza, L. & Brandão, M. L. Serotonergic mechanisms of the median raphe nucleus-dorsal hippocampus in conditioned fear: Output circuit involves the prefrontal cortex and amygdala. Behav. Brain Res. 203(2), 279–287. https://doi.org/10.1016/j.bbr.2009.05.017 (2009).
Liu, K. C. Activation and blockade of dorsal hippocampal Serotonin6 receptors regulate anxiety-like behaviors in a unilateral 6-hydroxydopamine rat model of Parkinson’s disease. Neurol. Res. 41(9), 791–801. https://doi.org/10.1080/01616412.2019.1611204 (2019).
Felix-Ortiz, A. C. & Tye, K. M. Amygdala inputs to the ventral hippocampus bidirectionally modulate social behavior. J. Neurosci. 34(2), 586–595. https://doi.org/10.1523/JNEUROSCI.4257-13.2014 (2014).
Adhikari, A. Distributed circuits underlying anxiety. Front. Behav. Neurosci. 28, 112. https://doi.org/10.3389/fnbeh.2014.00112 (2014).
Calhoon, G. G. & Tye, K. M. Resolving the neural circuits of anxiety. Nat. Neurosci. 10, 1394–1404. https://doi.org/10.1038/nn.4101 (2015).
Bruchas, M. R., Land, B. B., Lemos, J. C. & Chavkin, C. CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior. PLoS ONE 4(12), e8528. https://doi.org/10.1371/journal.pone.0008528 (2009).
Khatibi, V. A. et al. The glycolysis inhibitor 2-deoxy-D-glucose exerts different neuronal effects at circuit and cellular levels, partially reverses behavioral alterations and does not prevent nadph diaphorase activity reduction in the intrahippocampal kainic acid model of temporal lobe epilepsy. Neurochem. Res. 48(1), 210–228. https://doi.org/10.1007/s11064-022-03740-8 (2022).
Shepherd, J. K., Grewal, S. S., Fletcher, A., Bill, D. J. & Dourish, C. T. Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety. Psychopharmacology 116(1), 56–64. https://doi.org/10.1007/BF02244871 (1994).
Neely, C., Lane, C., Torres, J. & Flinn, J. The effect of gentle handling on depressive-like behavior in adult male mice: Considerations for human and rodent interactions in the laboratory. Behav. Neurol. 2018, 2976014. https://doi.org/10.1155/2018/2976014 (2018).
Buckinx, A. et al. Exploring refinement strategies for single housing of male C57BL/6JRj mice: Effect of cage divider on stress-related behavior and hypothalamic-pituitary-adrenal-axis activity. Front. Behav. Neurosci. 15, 743959. https://doi.org/10.3389/fnbeh.2021.743959 (2021).
Koenig, J. B. et al. Glycolytic inhibitor 2-deoxyglucose prevents cortical hyperexcitability after traumatic brain injury. JCI Insight. 5(11), e126506. https://doi.org/10.1172/jci.insight.126506 (2019).
Tucker, L. B. & McCabe, J. T. Behavior of male and female c57bl/6j mice is more consistent with repeated trials in the elevated zero maze than in the elevated plus maze. Front. Behav. Neurosci. 11, 13. https://doi.org/10.3389/fnbeh.2017.00013 (2017).
Belluscio, M. A., Mizuseki, K., Schmidt, R., Kempter, R. & Buzsáki, G. Cross-frequency phase-phase coupling between θ and γ oscillations in the hippocampus. J. Neurosci. 32(2), 423–435. https://doi.org/10.1523/JNEUROSCI.4122-11.2012 (2012).
Scheffer-Teixeira, R. & Tort, A. B. On cross-frequency phase-phase coupling between theta and gamma oscillations in the hippocampus. Elife 5, 20515. https://doi.org/10.7554/eLife.20515 (2016).
Schmued, L. C. & Hopkins, K. J. Fluoro-Jade B: A high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874(2), 123–130. https://doi.org/10.1016/s0006-8993(00)02513-0 (2000).
Arabadzisz, D., Antal, K., Parpan, F., Emri, Z. & Fritschy, J. M. Epileptogenesis and chronic seizures in a mouse model of temporal lobe epilepsy are associated with distinct EEG patterns and selective neurochemical alterations in the contralateral hippocampus. Exp. Neurol. 194(1), 76–90. https://doi.org/10.1016/j.expneurol.2005.01.029 (2005).
Mcdonald, A. J. & Mott, D. D. Interconnections and their role in learning and memory. 95, 797–820 (2017).
Pi, G. et al. Posterior basolateral amygdala to ventral hippocampal CA1 drives approach behaviour to exert an anxiolytic effect. Nat. Commun. 11, 1–15 (2020).
Johnson, F. K. et al. Amygdala hyper-connectivity in a mouse model of unpredictable early life stress. Transl. Psychiatry https://doi.org/10.1038/s41398-018-0092-z (2018).
Rau, A. R., Chappell, A. M., Butler, X. T. R., Ariwodola, O. J. & Weiner, J. L. Increased basolateral amygdala pyramidal cell excitability may contribute to the anxiogenic phenotype induced by chronic early-life stress. 35, 9730–9740 (2015).
Korotkova, T. et al. Reconciling the different faces of hippocampal theta: The role of theta oscillations in cognitive, emotional and innate behaviors. Neurosci. Biobehav. Rev. 85, 65–80. https://doi.org/10.1016/j.neubiorev.2017.09.004 (2018).
Blasco-Ibáñez, J. M. & Freund, T. F. Synaptic input of horizontal interneurons in stratum oriens of the hippocampal CA1 subfield: Structural basis of feed-back activation. Eur. J. Neurosci. 7(10), 2170–2180. https://doi.org/10.1111/j.1460-9568.1995.tb00638.x (1995).
Mattis, J. et al. Frequency-dependent, cell type-divergent signaling in the hippocamposeptal projection. J. Neurosci. 34(35), 11769–11780. https://doi.org/10.1523/JNEUROSCI.5188-13.2014 (2014).
Dannenberg, H. et al. Synergy of direct and indirect cholinergic septo-hippocampal pathways coordinates firing in hippocampal networks. J. Neurosci. 35(22), 8394–8410. https://doi.org/10.1523/JNEUROSCI.4460-14.2015 (2015).
Tóth, K., Freund, T. F. & Miles, R. Disinhibition of rat hippocampal pyramidal cells by GABAergic afferents from the septum. J. Physiol. 500(Pt 2), 463–474. https://doi.org/10.1113/jphysiol.1997.sp022033 (1997).
Borhegyi, Z., Varga, V., Szilágyi, N., Fabo, D. & Freund, T. F. Phase segregation of medial septal GABAergic neurons during hippocampal theta activity. J. Neurosci. 24(39), 8470–8479. https://doi.org/10.1523/JNEUROSCI.1413-04.2004 (2004).
Bartos, M., Vida, I. & Jonas, P. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat. Rev. Neurosci. 8(1), 45–56. https://doi.org/10.1038/nrn2044 (2007).
Mann, E. O., Suckling, J. M., Hajos, N., Greenfield, S. A. & Paulsen, O. Perisomatic feedback inhibition underlies cholinergically induced fast network oscillations in the rat hippocampus in vitro. Neuron 45(1), 105–117. https://doi.org/10.1016/j.neuron.2004.12.016 (2005).
Chen, N. et al. A macaque model of mesial temporal lobe epilepsy induced by unilateral intrahippocampal injection of kainic Acid. PLoS ONE 8(8), e72336. https://doi.org/10.1371/journal.pone.0072336 (2013).
Fonnum, F. & Walaas, I. The effect of intrahippocampal kainic acid injections and surgical lesions on neurotransmitters in hippocampus and septum. J. Neurochem. 31(5), 1173–1181. https://doi.org/10.1111/j.1471-4159.1978.tb06241.x (1978).
Stoop, R. & Pralong, E. Functional connections and epileptic spread between hippocampus, entorhinal cortex and amygdala in a modified horizontal slice preparation of the rat brain. Eur. J. Neurosci. 12(10), 3651–3663. https://doi.org/10.1046/j.1460-9568.2000.00253.x (2000).
Kocsis, B., Di Prisco, G. V. & Vertes, R. P. Theta synchronization in the limbic system: The role of Gudden’s tegmental nuclei. Eur J Neurosci. 13(2), 381–388 (2001).
Okonogi, T., Nakayama, R., Sasaki, T. & Ikegaya, Y. Characterization of peripheral activity states and cortical local field potentials of mice in an elevated plus maze test. Front. Behav. Neurosci. 12, 62. https://doi.org/10.3389/fnbeh.2018.00062 (2018).
Jacinto, L. R., Cerqueira, J. J. & Sousa, N. Patterns of theta activity in limbic anxiety circuit preceding exploratory behavior in approach-avoidance conflict. Front. Behav. Neurosci. 10, 171. https://doi.org/10.3389/fnbeh.2016.00171 (2016).
Likhtik, E., Stujenske, J. M., Topiwala, M. A., Harris, A. Z. & Gordon, J. A. Prefrontal entrainment of amygdala activity signals safety in learned fear and innate anxiety. Nat. Neurosci. 17(1), 106–113. https://doi.org/10.1038/nn.3582 (2014).
Acknowledgements
This work was supported financially by Elite Researcher Grant Committee under award numbers 996644 from National Institute for Medical Research Development (NIMAD, Grant No. 996644) and in part by Shahid Beheshti University of Medical Sciences (Grant No. 24402), Tehran, Iran.
Author information
Authors and Affiliations
Contributions
V.A.K: data collection; analysis and interpretation of results; draft manuscript preparation; M.S.: analysis and interpretation of results; M.R.: histology data collection and analysis; M.Re.: data collection; M.N.: Software. S.D.: histology data collection and interpretation of results; S.De.: histology data analysis; M.R.R.: Project administration, Writing-Reviewing and Editing; J.M.Z.: Project administration, Reviewing and Editing; MJa: Reviewing and Editing; N.H.: Editing; G.B. Editing; M.J.: Conceptualization, Project administration, Supervision, Funding acquisition.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Khatibi, V.A., Salimi, M., Rahdar, M. et al. Glycolysis inhibition partially resets epilepsy-induced alterations in the dorsal hippocampus-basolateral amygdala circuit involved in anxiety-like behavior. Sci Rep 13, 6520 (2023). https://doi.org/10.1038/s41598-023-33710-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-33710-1
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.